Australia
# |
Name |
Cash and Short-Term Investments |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 1.66 B
|
June 30, 2024 | USD 169.95 | -0.56% |
|
Australia |
|
2 |
USD 430.06 M
|
June 30, 2024 | USD 17.72 | 0.58% |
|
Australia |
|
3 |
USD 342.45 M
|
June 30, 2024 | USD 195.76 | 0.28% |
|
Australia |
|
4 |
USD 122.60 M
|
June 30, 2024 | USD 7.27 | 0.71% |
|
Australia |
|
5 |
USD 121.27 M
|
June 30, 2024 | USD 2.09 | 0.97% |
|
Australia |
|
6 |
USD 99.53 M
|
June 30, 2024 | USD 2.89 | 2.85% |
|
Australia |
|
7 |
USD 83.93 M
|
Dec. 31, 2023 | USD 18.33 | -0.84% |
|
Australia |
|
8 |
USD 62.56 M
|
June 30, 2024 | USD 1.90 | -4.74% |
|
Australia |
|
9 |
USD 40.07 M
|
June 30, 2024 | USD 0.87 | -0.82% |
|
Australia |
|
10 |
USD 30.64 M
|
June 30, 2024 | USD 1.23 | -0.40% |
|
Australia |
|
11 |
USD 30.08 M
|
June 30, 2024 | USD 0.74 | 1.48% |
|
Australia |
|
12 |
USD 28.30 M
|
June 30, 2024 | USD 1.90 | 0.29% |
|
Australia |
|
13 |
USD 21.00 M
|
Dec. 31, 2023 | USD 6.16 | 2.82% |
|
Australia |
|
14 |
USD 17.90 M
|
June 30, 2024 | USD 2.33 | 0.08% |
|
Australia |
|
15 |
USD 7.99 M
|
Dec. 31, 2023 | USD 1.45 | -3.95% |
|
Australia |
|
16 |
USD 7.56 M
|
June 30, 2024 | USD 0.74 | 0.62% |
|
Australia |
The Biotechnology company in Australia with the highest Cash and Short-Term Investments is CSL Limited (ASX: CSL.AX) at USD 1.66 B.
The Biotechnology company in Australia with the lowest Cash and Short-Term Investments is Monash IVF Group Limited (ASX: MVF.AX) at USD 7.56 M.
The top 10 Biotechnology companies in Australia by Cash and Short-Term Investments are CSL Limited, Sonic Healthcare Limited, Cochlear Limited, Clinuvel Pharmaceuticals Limited, Immutep Limited, Mayne Pharma Group Limited, Telix Pharmaceuticals Limited, Mesoblast Limited, Healius Limited and PolyNovo Limited.
The bottom 10 Biotechnology companies in Australia by Cash and Short-Term Investments are Monash IVF Group Limited, Cyclopharm Limited, Australian Clinical Labs Limited, Anteris Technologies Ltd, Integral Diagnostics Limited, Cogstate Limited, PolyNovo Limited, Healius Limited, Mesoblast Limited and Telix Pharmaceuticals Limited.